Suppr超能文献

筛查项目中结肠镜检查严重并发症的风险因素。

Risk factors for severe complications of colonoscopy in screening programs.

机构信息

Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain.

Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain; General Directorate Public Health, Valencian Community, Spain.

出版信息

Prev Med. 2019 Jan;118:304-308. doi: 10.1016/j.ypmed.2018.11.010. Epub 2018 Nov 8.

Abstract

Severe complications (SC) in colonoscopy represent the most important adverse effect of colorectal cancer screening programs (CRCSP). The objective is to evaluate the risk factors for SC in colonoscopy indicated after a positive fecal occult blood test in population-based CRCSP. The SC (n = 161) identified from 48,730 diagnostic colonoscopies performed in a cohort of all the women and men invited from 2000 to 2012 in 6 CRCSP in Spain. A total of 318 controls were selected, matched for age, sex and period when the colonoscopy was performed. Conditional logistic regression models were estimated. The analysis was performed separately in groups: immediate-SC (same day of the colonoscopy); late-SC (between 1 and 30 days after); perforation; and bleeding events. SC occurred in 3.30‰ of colonoscopies. Prior colon disease showed a higher risk of SC (OR = 4.87). Regular antiplatelet treatment conferred a higher risk of overall SC (OR = 2.80) and late-SC (OR = 9.26), as did regular anticoagulant therapy (OR = 3.47, OR = 7.36). A history of pelvic-surgery or abdominal-radiotherapy was a risk factor for overall SC (OR = 5.03), immediate-SC (OR = 8.49), late-SC (OR = 4.65) and perforation (OR = 21.59). A finding of adenoma or cancer also showed a higher risk of overall SC (OR = 8.71), immediate-SC (OR = 12.67), late-SC (OR = 4.08), perforation (OR = 4.69) and bleeding (OR = 17.02). The risk of SC doesn't vary depending on the type of preparation or type of anesthesia. Knowing the clinical history of patients such as regular previous medication and history of surgery or radiotherapy, as well as the severity of the findings during the colonoscopy process could help to focus prevention measures in order to minimize SC in CRCSP.

摘要

结肠镜检查的严重并发症 (SC) 是结直肠癌筛查计划 (CRCSP) 中最重要的不良影响。本研究旨在评估人群基础结直肠癌筛查计划中阳性粪便潜血试验后进行结肠镜检查的 SC 的危险因素。在西班牙 6 个 CRCSP 中,对 2000 年至 2012 年期间邀请的所有女性和男性进行的 48730 例诊断性结肠镜检查中,确定了 161 例 SC。共选择了 318 名对照,年龄、性别和结肠镜检查时的时间匹配。估计了条件逻辑回归模型。分析分别在以下组中进行:即刻性 SC(结肠镜检查当天);迟发性 SC(结肠镜检查后 1 至 30 天);穿孔;和出血事件。结肠镜检查中 SC 的发生率为 3.30‰。既往结肠疾病显示 SC 风险更高(OR=4.87)。定期抗血小板治疗增加了总体 SC(OR=2.80)和迟发性 SC(OR=9.26)的风险,常规抗凝治疗也增加了总体 SC(OR=3.47)和迟发性 SC(OR=7.36)的风险。盆腔手术或腹部放疗史是总体 SC(OR=5.03)、即刻性 SC(OR=8.49)、迟发性 SC(OR=4.65)和穿孔(OR=21.59)的危险因素。腺瘤或癌症的发现也显示出总体 SC(OR=8.71)、即刻性 SC(OR=12.67)、迟发性 SC(OR=4.08)、穿孔(OR=4.69)和出血(OR=17.02)的风险更高。SC 的风险不取决于准备类型或麻醉类型。了解患者的临床病史,如常规用药史和手术或放疗史,以及结肠镜检查过程中的严重程度,有助于集中预防措施,尽量减少 CRCSP 中的 SC。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验